First human trial supports Israeli immune therapy for Alzheimer’s...

The first human trial of an Israeli-developed immune therapy for Alzheimer’s disease has produced supportive early results. The approach seeks to restore immune functions that naturally decline with age.

It differs from conventional treatments by not targeting amyloid plaques directly.